Skip to main content

Advertisement

Log in

Active malignancy in patients with renal vein thrombosis: influence upon clinical course and survival

  • Original Article
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

Background

Renal vein thrombosis (RVT) is a rare event with myriad clinical manifestations. Published experience regarding the clinical course and management of RVT in patients beyond the neonatal period is limited to case reports and small case series.

Methods

A multicenter retrospective review of consecutive admitted patients with diagnosed RVT between January 2000 and May 2015 at three different university hospitals.

Results

Thirty-nine patients (53.8 % men and 46.2 % women) were included. Median age was 58 years. Malignancy (n = 19, 48.7 %), nephrotic syndrome (n = 8, 20.5 %) and infection (n = 5, 12.8 %), were the most common underlying conditions. Compared to non-cancer patients, patients with active cancer tended to be significantly older (mean age 63 ± 18 vs. 37 ± 22 years, P = 0.001) and presented with non-acute symptoms (P = 0.01) and unrevealing physical findings (P = 0.02). Thrombosis extension beyond the renal vein occurred in 69.2 % of cases and was more common in cancer patients (P = 0.001). Anticoagulation therapy was administered in 71.8 % of patients leading to resolution of thrombus in most cases (30/32 patients, 94 %) during follow-up evaluation. There were six recurrent thrombotic events during a mean follow-up of 35 ± 43 months. Nine patients (28 %) died during follow-up, all of them with malignancy.

Conclusion

Active cancer is the most common cause of RVT and should be excluded when RVT is diagnosed. Clinical course of RVT in cancer patients is more indolent and diagnosis requires high index of suspicion. Survival rates are governed by the presence of malignancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Rayer P. Traité des maladies des reins et des altérations de la sécrétion urinaire. Paris: J.-B. Baillière; 1841. p. 1839–40.

  2. Witz M, Korzets Z. Renal vein occlusion: diagnosis and treatment. Isr Med Assoc J. 2007;9:402–5.

    PubMed  Google Scholar 

  3. Kosch A, Kuwertz-Broking E, Heller C, Kurnik K, Schobess R, Nowak-Gottl U. Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up. Blood. 2004;104:1356–60.

    Article  CAS  PubMed  Google Scholar 

  4. Asghar M, Ahmed K, Shah SS, Siddique MK, Dasgupta P, Khan MS. Renal vein thrombosis. Eur J Vasc Endovasc Surg. 2007;34:217–23.

    Article  CAS  PubMed  Google Scholar 

  5. Wysokinski WE, Gosk-Bierska I, Greene EL, Grill D, Wiste H, McBane RD, et al. Clinical characteristics and long-term follow-up of patients with renal vein thrombosis. Am J Kidney Dis. 2008;51:224–32.

    Article  PubMed  Google Scholar 

  6. Lionaki S, Derebail VK, Hogan SL, Barbour S, Lee T, Hladunewich M, et al. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012;7:43–51.

    Article  CAS  PubMed  Google Scholar 

  7. Radhakrishnan J. Venous thromboembolism and membranous nephropathy: so what’s new? Clin J Am Soc Nephrol. 2012;7:3–4.

    Article  PubMed  Google Scholar 

  8. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006;118:397–407.

    Article  CAS  PubMed  Google Scholar 

  9. Brandao LR, Simpson EA, Lau KK. Neonatal renal vein thrombosis. Semin Fetal Neonatal Med. 2011;16:323–8.

    Article  PubMed  Google Scholar 

  10. Llach F, Papper S, Massry SG. The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med. 1980;69:819–27.

    Article  CAS  PubMed  Google Scholar 

  11. Wei LQ, Rong ZK, Gui L, Shan RD. CT diagnosis of renal vein thrombosis in nephrotic syndrome. J Comput Assist Tomogr. 1991;15:454–7.

    Article  CAS  PubMed  Google Scholar 

  12. Gatewood OM, Fishman EK, Burrow CR, Walker WG, Goldman SM, Siegelman SS. Renal vein thrombosis in patients with nephrotic syndrome: CT diagnosis. Radiology. 1986;159:117–22.

    Article  CAS  PubMed  Google Scholar 

  13. Ogunbiyi OA. Renal vein thrombosis in patients with nephrotic syndrome: CT diagnosis. Afr J Med Med Sci. 1995;24:33–40.

    CAS  PubMed  Google Scholar 

  14. Tait C, Baglin T, Watson H, Laffan M, Makris M, Perry D, et al. Guidelines on the investigation and management of venous thrombosis at unusual sites. Br J Haematol. 2012;159:28–38.

    Article  PubMed  Google Scholar 

  15. Kuhle S, Massicotte P, Chan A, Mitchell L. A case series of 72 neonates with renal vein thrombosis. Data from the 1–800-NO-CLOTS Registry. Thromb Haemost. 2004;92:729–33.

    CAS  PubMed  Google Scholar 

  16. Kowal J, Figur A, Hitzig WM. Renal vein thrombosis and the nephrotic syndrome with complete remission. J Mt Sinai Hosp N Y. 1963;30:47–58.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yosef Kalish.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rottenstreich, A., Barzilai, M., Da’as, N. et al. Active malignancy in patients with renal vein thrombosis: influence upon clinical course and survival. Clin Exp Nephrol 21, 49–54 (2017). https://doi.org/10.1007/s10157-016-1245-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-016-1245-0

Keywords

Navigation